The risk level of Nippon India Pharma Fund - Direct Plan ... the AUM of Nippon India Pharma Fund - Direct Plan - Growth Plan The assets under Management (AUM) of Nippon India Pharma Fund ...

Global events can have a profound impact on all industries, with the pharmaceutical industry ... transparency and integrating supply chain risk management into your governance and leadership ...

BioMarin Pharmaceutical Inc. ( NASDAQ: BMRN) Q4 2024 Earnings Conference Call February 19, 2025 4:30 PM ET Traci McCarty - Head of IR Alexander Hardy - President and CEO Brian Mueller - EVP and CFO ...

The Korea Exchange said on the 14th that it has pre-announced matters to focus on regarding the corporate governance reports ...

The Union ministry of health and family welfare has issued the final notification extending the deadline for implementation of the revised Schedule M manufacturing standards to one more year for the ...

subjects healthcare and pharmaceutical manufacturers to strict cybersecurity mandates. Gaps, however, still exist. In the EU, 10% of companies in the sector lack a vulnerability management plan ...

SELARSDI is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and pediatric patients 6 years and older, and the treatment of adult patients ...

Humana's 2024 earnings reveal revenue growth but major structural issues impacting profitability. Learn about risks, new ...

WASHINGTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical ... “plan,” or the negative of these terms and similar ...

Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the "Company”), a pharmaceutical company focused on developing new ...

Frustrated by spiraling drug costs, California lawmakers want to increase oversight of pharmaceutical industry intermediaries ...